StonvexLoading…
StonvexStonvexStonvexCore line items from ABCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $75.13M | $28.83M | $38.02M | $485.42M |
Operating Income | $-217.10M | $-314.77M | $-237.21M | $216.51M |
Net Income | $-146.41M | $-162.86M | $-146.40M | $158.52M |
EPS (Diluted) | $-0.49 | $-0.55 | $-0.51 | $0.50 |
Total Assets | $1.36B | $1.36B | $1.49B | $1.54B |
Total Liabilities | $390.05M | $304.47M | $335.78M | $307.63M |
Cash & Equivalents | $128.51M | $156.32M | $133.32M | $386.54M |
Free Cash Flow OCF − CapEx | $-174.07M | $-186.95M | $-120.82M | $206.70M |
Shares Outstanding | 300.60M | 295.76M | 290.82M | 286.85M |